When Cancer Treatment Consumes Life: Lymphoma Patients Reveal the Hidden Burden of Time Toxicity

For decades, the success of cancer medicine has been measured in survival rates, tumor response, and years of life gained. But a growing body of research is turning attention to a quieter, less visible cost of modern oncology: the sheer amount of time that treatment steals from patients’ lives. A new qualitative study from China now offers one of the most detailed portraits yet of what researchers call time toxicity among young and middle-aged patients with lymphoma, revealing how hospital visits, waiting rooms, and cross-city travel can quietly reorganize every hour of a person’s existence. The findings, published in Supportive Care in Cancer, suggest that the temporal burden of cancer care may be as consequential as its physical and financial costs.

The research team, led by Danyang Li and colleagues at the First Affiliated Hospital of Zhejiang University School of Medicine in Hangzhou, conducted in-depth, face-to-face interviews with fifteen lymphoma patients aged 18 to 50 between June and December 2025. All participants were undergoing active treatment at the hematology department of a tertiary Grade A hospital. Using purposive sampling with maximum variation, the researchers deliberately recruited a diverse group spanning different ages, employment statuses, lymphoma subtypes, disease stages, treatment modalities, and places of residence. Interviews lasted between 25 and 58 minutes, totaling 546 minutes of recorded conversation, and the team reached code saturation by the thirteenth interview, confirming it with two additional sessions.

What sets this study apart methodologically is its theoretical grounding in Time-Geography Theory, a framework developed by Swedish geographer Torsten Hägerstrand in 1970. The theory explains how everyday human activity is shaped by three kinds of constraints: capability constraints tied to physical capacity, coupling constraints requiring presence at particular times and places, and authority constraints imposed by institutions. Rather than forcing the data into these categories, the researchers used the framework as a sensitizing lens, allowing themes to emerge inductively through conventional content analysis. The result is a picture of time toxicity that is not merely a count of healthcare contact days but a lived, spatially embedded experience.

The analysis revealed five interconnected themes. The first was a multidimensional time burden driven by treatment itself. Participants described schedules dominated by frequent hospital visits for blood tests, catheter maintenance, and injections to manage side effects, often recurring several times a week. One patient explained that pre-admission tests and hospital stays typically consumed about a week, while follow-up appointments required roughly two days each week. Another described traveling between a local hospital twice weekly for blood tests and a tertiary hospital for injections whenever white blood cell counts dropped, spending several days each week in transit between facilities.

Perhaps more striking were the hidden time costs that never appear on any treatment schedule. Patients reported that although actual consultations might last only minutes, registration, queuing, waiting for examinations, and delays in receiving results could consume entire days. One participant captured the frustration succinctly: occasionally waiting several hours for a consultation that lasts merely a few minutes, with the waiting itself being the most draining aspect. Compounding this friction, treatment cycles often overlapped with recovery periods, leaving patients feeling that the next round of chemotherapy was scheduled before their bodies had recuperated from the last. Complications such as port infections, fevers, and abrupt changes in treatment plans following PET-CT results added further layers of unpredictability and additional visits.

The second and third themes exposed how these temporal demands cascaded into every corner of patients’ lives. Career interruptions were particularly acute for this age group, striking just as professional trajectories were gaining momentum. Participants described missed promotions, eroded professional identity, and mounting financial strain, with one noting that sick leave pay constituted only a fraction of their salary and that the family had depleted all its savings. Family responsibilities were redistributed as spouses, parents, and relatives absorbed childcare, household chores, and hospital accompaniment. Social life contracted sharply as weakened immunity and infection fears confined patients to a narrow orbit of hospital and home, with some avoiding public transport entirely and one participant staying in a hotel near the hospital throughout six treatment cycles, returning home only three or four times to avoid crowded trains.

Healthcare mobility emerged as a distinct dimension of the burden, shaped by the interaction of geography, transportation, and physical capacity. Patients traveling from cities such as Taizhou faced journeys exceeding three hours each way, combining high-speed rail with taxi rides, and arriving exhausted before treatment even began. Urban congestion and parking difficulties extended even short trips, with one patient remarking that finding a parking space could be harder than seeing the doctor. Chemotherapy-related fatigue and dizziness made long-distance travel physically hazardous; one participant fainted on the way home and afterward became apprehensive about leaving the house. The economic dimension was equally tangible, as many patients opted for taxis over public transport to reduce infection risk, accumulating costs that added up visit after visit.

The emotional toll of this temporal disruption formed the fourth theme. Participants described anxiety over the uncertain duration and effectiveness of treatment, nervousness each time blood test results arrived, and a profound sense of disconnection from society while peers continued working and progressing through normal life stages. Prolonged waiting and repeated hospital trips produced cumulative emotional exhaustion and irritability, illustrating how sustained time demands compound psychological distress. The researchers interpret these emotional consequences as partly reflecting disrupted temporal rhythms and a reduced sense of control over personal time, a framing that links psychological suffering directly to the organization of healthcare itself.

Yet the study is not solely a catalog of burdens. The fifth theme documented multilevel coping strategies that patients deployed to reclaim some measure of control. Several used digital tools proactively, scheduling PET-CT scans through online hospital platforms and sending blood test results to physicians via WeChat to avoid unnecessary trips. Others practiced health-oriented self-management, learning the predictable patterns of their blood count fluctuations after chemotherapy so they could time blood tests and injections more efficiently, while adjusting sleep, diet, and exercise routines to reduce infection risk. Cognitive reframing played a role as well: some listened to music during infusions to manage anxiety, while others reported that illness had prompted them to slow down, rethink their priorities, and value time with family more deeply. Family members, meanwhile, formed an essential support infrastructure, handling daily tasks so patients could focus on treatment and recovery.

The study’s implications reach well beyond the hematology ward. The authors argue that reducing time toxicity requires attention not only to treatment schedules but to modifiable care-process factors such as waiting times, fragmented appointments, and the coordination of supportive care. They point to prior evidence, including analyses of the CCTG LY.12 trial showing that lymphoma regimens with comparable oncologic outcomes could differ substantially in healthcare contact days, and a Japanese database study demonstrating that time toxicity of R-CHOP varies with treatment setting and patient factors. Nurse-led navigation, anticipatory information about expected time demands, coordinated scheduling, telehealth, and decentralized supportive care all emerge as promising avenues. The authors caution that their single-center study in eastern China, subjective self-reported data, and single-time-point interviews limit generalizability, and they call for multicenter, longitudinal, mixed-methods research integrating patient experiences with objective measures of time use. As survival from lymphoma continues to improve, the study makes a compelling case that how patients spend their time during treatment is not a peripheral concern but a central measure of the quality of cancer care itself.

Subject of Research: Time toxicity experiences and coping strategies among young and middle-aged lymphoma patients in China

Article Title: Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study

Article References: Li, D., Zheng, K., Chen, L., & Zhang, M. (2026). Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study. Supportive Care in Cancer, 34(10), Article 976. https://doi.org/10.1007/s00520-026-11213-9

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11213-9

Keywords: time toxicity, lymphoma, cancer care, qualitative research, Time-Geography Theory, supportive care, healthcare mobility, coping strategies, patient experience, China, nursing, treatment burden